First Header Logo Second Header Logo

Connection

Karl-Erik Andersson to Cannabinoids

This is a "connection" page, showing publications Karl-Erik Andersson has written about Cannabinoids.
Connection Strength

0.288
  1. Andersson KE. Potential Future Pharmacological Treatment of Bladder Dysfunction. Basic Clin Pharmacol Toxicol. 2016 Oct; 119 Suppl 3:75-85.
    View in: PubMed
    Score: 0.116
  2. Campeau L, Füllhase C, Sawada N, Gratzke C, Hedlund P, Howlett AC, Andersson KE. Characterization of bladder function in a cannabinoid receptor type 2 knockout mouse in vivo and in vitro. Neurourol Urodyn. 2014 Jun; 33(5):566-70.
    View in: PubMed
    Score: 0.096
  3. Gratzke C, Streng T, Stief CG, Downs TR, Alroy I, Rosenbaum JS, Andersson KE, Hedlund P. Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats. Eur Urol. 2010 Jun; 57(6):1093-100.
    View in: PubMed
    Score: 0.076
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.